UNIVET establishes Wavegrande Beijing Research Institute, officially launching a new clinical research brand.

Wavegrande BRI takes systematic R&D as its core strategy, aiming to build a high-level scientific research platform that excels domestically and connects internationally.

In the field of pharmaceutical raw materials and intermediates, Wavegrande BRI focus on the design and synthesis of key molecules, establishing a complete technology chain from basic research to pilot-scale validation. This provides high-purity, high-consistency raw material support for innovative drug development.

For feed additives, Wavegrande BRI prioritize the development of green, safe, and efficient new products. Targeting the sustainable upgrade of animal husbandry, we strive to achieve multiple goals of antibiotic replacement, efficiency enhancement, and environmental friendliness.